Teeka Tiwari’s Set For Life Summit revealed the Palm Beach Venture‘s biotech boom research and highlighted the The Next Aspirin Biotech Boom Report that details orphan drug status, or orphan drug designations as part of Teeka’s first-ever pre-IPO biotech recommendation.
Table of Contents
- 1 Which Biotech Stock Pick Teeka Tiwari says is the Next Aspirin?
- 2 What’s Included With Your Palm Beach Venture Subscription?
- 3 Pricing
- 4 Is There any Guarantee Or Refund Policy in Place?
- 5 Final Word
Which Biotech Stock Pick Teeka Tiwari says is the Next Aspirin?
Teeka’s team is on 24/7 standby.
As we speak, they’re monitoring this pre-IPO biotech deal preparing to go public… And they can confirm there is still space left to get in before funding is closed.
But please understand: Things are moving fast.
Venture capital investment is accelerating at an unprecedented pace. Just last night we reported they invested $5.5 billion in companies just like Teeka’s pre-IPO deal.
And today we got word it’s up to $6.6 billion.
An extra $1.2 billion in the blink of an eye.
If you want to discover why venture capital is foaming at the mouth for these pre-IPO deals, act now and watch this special presentation…
If this pre-IPO biotech is funded by midnight, we’re going to pull Teeka’s presentation offline.
The Next Aspirin Biotech Boom Research Report comes for free when you subscribe for Teeka’s elite research Palm Beach Venture.
What’s Included With Your Palm Beach Venture Subscription?
Here’s Everything You’ll Receive:
1 Year of Palm Beach Venture
Palm Beach Venture is Teeka’s most elite research service. Your membership provides you with a suite of premium benefits. Including…
- Quarterly pre-IPO recommendations: At least once every quarter, Teeka will share with you his latest pre-IPO recommendation. You will never need accredited status to buy into these recommendations… In other words, you can get in on the deal, no matter your current level of wealth.
- Bonus small-cap recommendations: Teeka and his team have been uncovering tiny small-caps in the biggest mega trends poised to skyrocket. Approximately every month you don’t receive a pre-IPO recommendation, Teeka will share with you his top small-cap stock recommendation.
- Model Portfolio: Teeka’s team of hedge fund-level analysts produce an up-to-date model portfolio for Palm Beach Venture. It’s complete with open dates, buy-up-to prices, and actions to take… which makes following Teeka’s pre-IPO recommendations and small-cap recommendations easy.
- Members-Only Website: This portal hosts all of your member resources. Here you’ll find the model portfolio, latest issues, recommendations, and updates Teeka and his team send you. Additionally, this is where you’ll find the Palm Beach Venture Manifesto to help you hit the ground running.
Alerts: New Recommendation Notifications
The moment Teeka issues a new pre-IPO recommendation or small-cap play, you have the option to be notified by a convenient smartphone notification.
Report: The Next Aspirin
Discover how to get shares in Teeka’s first-ever pre-IPO biotech recommendation, BEFORE it goes public. Nine out of the top 10 best-selling treatments in biotech history secured orphan drug status. The FDA just awarded this tiny biotech the same coveted status. Plus, the EMA (Europe’s FDA) has granted this biotech the same guarantee as well. Giving this biotech not one — but TWO — potential millionaire-making guarantees.
Teeka’s Urgent Pre-IPO Briefing: #11
Teeka’s contact is one of the most successful VCs of our generation. 10 deals alone have built his billion dollar fortune. And his next big deal could go public on the Nasdaq (Or NYSE) before the end of 2020. Inside #11, you’ll discover how to invest alongside this billionaire in his 11th deal, under the same exact terms: $0.75 per share.
The Palm Beach Venture Hotlist
In this briefing, you’ll discover THREE MORE pre-IPO deals Teeka recommends you get shares in immediately.
Palm Beach Venture typically retails for $5,000 a year. But as a Set For Life attendee, you get a special deal.
Today, you can join Teeka’s most elite research service for only $2,500.
(And if you’re a Palm Beach Confidential member, you’ll receive an even better deal. You can join for just $2,000.)
Is There any Guarantee Or Refund Policy in Place?
You’re protected by 90-day customer satisfaction guarantee. Which means that if you don’t find Palm Beach Venture perfect for you in every way, simply contact customer service team at 800-681-6533 within the first 90 days of your membership. They will issue you a full credit refund that you can apply to any of Palm Beach Group other research services.
You just saw how a tiny stake in the right pre-IPO opportunity can literally set you up for life…
And now you have a chance to claim access to ALL of Teeka’s pre-IPO research for a massive discount.
Remember, pre-IPO investing gives you a chance to earn life-changing gains… quickly.
Consider that pre-IPO investors made 35,198% on ADC on IPO Day, but Main Street only made 156%.
Or the 50,400% pre-IPO investors made on API, versus the 152% Main Street made.
Or the 130,000% return on Vaxcyte but only 92% for Main Street…
Even a tiny $500 stake into each of these opportunities could have handed you over $1 million in profits…
Teeka JUST published a brand new report about a pre-IPO bio-tech company that just got FDA approval…
This report is called “The Next Aspirin.”
And you can access it in the next few minutes…
When you do, you’ll get access to Teeka’s service, Palm Beach Venture, which includes all of Teeka’s pre-IPO research – for a $2,500 discount.
Sound good to you?
If you’ve never done any pre-IPO investing, you should know that Teeka also has a primer he’s ready to send to you. It’s called Palm Beach Venture Manifesto. It shows you everything you need to know to get started.
(By the way, if you are already a Palm Beach Confidential subscriber, Teeka has a special offer for you. Just click here!)